{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:31:40Z","timestamp":1784597500899,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,27]]},"DOI":"10.7759\/cureus.27338","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T13:27:50Z","timestamp":1658928470000},"source":"Crossref","is-referenced-by-count":3,"title":["Pneumothorax as a Complication of Bevacizumab-Containing Chemotherapy: A Systematic Review of Case Reports"],"prefix":"10.7759","author":[{"given":"Shafi","family":"Rehman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameed","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Sivanandan","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnoor","family":"Sukaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shameera","family":"Shaik Masthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazmah","family":"Shahrukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Min Allah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hamza","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya M","year":"2011","unstructured":"Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011, 2:1097-105. 10.1177\/1947601911423031","journal-title":"Genes Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2701","article-title":"Lessons from the adjuvant bevacizumab trial on colon cancer: what next?","volume":"29","author":"Van Cutsem E","year":"2011","unstructured":"Van Cutsem E, Lambrechts D, Prenen H, Jain RK, Carmeliet P. Lessons from the adjuvant bevacizumab trial on colon cancer: what next?. J Clin Oncol. 2011, 29:1-4. 10.1200\/JCO.2010.32.2701","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2012.01.03","article-title":"Bilateral pneumothorax after bevacizumab-containing chemotherapy in fibrosarcoma","volume":"4","author":"Zhang Y","year":"2012","unstructured":"Zhang Y, Yang H, Zhao M, He J. Bilateral pneumothorax after bevacizumab-containing chemotherapy in fibrosarcoma. J Thorac Dis. 2012, 4:229-31. 10.3978\/j.issn.2072-1439.2012.01.03","journal-title":"J Thorac Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-014-9420-y","article-title":"Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions","volume":"17","author":"Vasudev NS","year":"2014","unstructured":"Vasudev NS, Reynolds AR. Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions. Angiogenesis. 2014, 17:471-94. 10.1007\/s10456-014-9420-y","journal-title":"Angiogenesis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.5624","article-title":"Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer","volume":"93","author":"Thornton AD","year":"2006","unstructured":"Thornton AD, Ravn P, Winslet M, Chester K. Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. Br J Surg. 2006, 93:1456-63. 10.1002\/bjs.5624","journal-title":"Br J Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2006.08.002","article-title":"Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer","volume":"33","author":"Ellis LM","year":"2006","unstructured":"Ellis LM. Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer. Semin Oncol. 2006, 33:S1-7. 10.1053\/j.seminoncol.2006.08.002","journal-title":"Semin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0302-9","article-title":"Bevacizumab: a review of its use in advanced cancer","volume":"74","author":"Keating GM","year":"2014","unstructured":"Keating GM. Bevacizumab: a review of its use in advanced cancer. Drugs. 2014, 74:1891-925. 10.1007\/s40265-014-0302-9","journal-title":"Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyq195","article-title":"Pneumothorax after bevacizumab-containing chemotherapy: a case report","volume":"41","author":"Yang SH","year":"2011","unstructured":"Yang SH, Lin JK, Chen WS, et al.. Pneumothorax after bevacizumab-containing chemotherapy: a case report. Jpn J Clin Oncol. 2011, 41:269-71. 10.1093\/jjco\/hyq195","journal-title":"Jpn J Clin Oncol"},{"key":"ref9","article-title":"[Pneumothorax after treatment with bevacizumab-containing chemotherapy for breast cancer - a case report]","volume":"41","author":"Makino T","year":"2014","unstructured":"Makino T, Kudo S, Ogata T. [Pneumothorax after treatment with bevacizumab-containing chemotherapy for breast cancer - a case report]. Gan To Kagaku Ryoho. 2014, 41:233-5.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4172\/2161-105X.S14-001","article-title":"A rare case of persistent pneumothorax in non-small cell lung cancer on bevacizumab therapy","volume":"S14","author":"Koh H","year":"2013","unstructured":"Koh H, Kamiishi N, Kimura Y, et al.. A rare case of persistent pneumothorax in non-small cell lung cancer on bevacizumab therapy. J Pulm Respir Med. 2013, S14:001. 10.4172\/2161-105X.S14-001","journal-title":"J Pulm Respir Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.7155","article-title":"A rupture of a lung metastatic lesion of colon cancer, leading to pneumothorax caused by bevacizumab","volume":"55","author":"Iida T","year":"2016","unstructured":"Iida T, Yabana T, Nakagaki S, Adachi T, Kondo Y. A rupture of a lung metastatic lesion of colon cancer, leading to pneumothorax caused by bevacizumab. Intern Med. 2016, 55:3125-9. 10.2169\/internalmedicine.55.7155","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2013.06.007","article-title":"Chemotherapy-induced secondary pneumothorax","volume":"50","author":"Bazan F","year":"2014","unstructured":"Bazan F, Vollmer I, Gayete A. Chemotherapy-induced secondary pneumothorax. Arch Bronconeumol. 2014, 50:44. 10.1016\/j.arbres.2013.06.007","journal-title":"Arch Bronconeumol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000153","article-title":"Endobronchial Watanabe spigot placement for a secondary pneumothorax","volume":"22","author":"Ueda Y","year":"2015","unstructured":"Ueda Y, Huang CL, Itotani R, Fukui M. Endobronchial Watanabe spigot placement for a secondary pneumothorax. J Bronchology Interv Pulmonol. 2015, 22:278-80. 10.1097\/LBR.0000000000000153","journal-title":"J Bronchology Interv Pulmonol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2019.1868","article-title":"Pneumothorax following combination chemotherapy with bevacizumab: a case report and review of the literature","volume":"11","author":"Alrifai T","year":"2019","unstructured":"Alrifai T, Saba R, Rifai D, Pandit S, Kozma KE. Pneumothorax following combination chemotherapy with bevacizumab: a case report and review of the literature. Mol Clin Oncol. 2019, 11:173-6. 10.3892\/mco.2019.1868","journal-title":"Mol Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v11.i7.504","article-title":"Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: a case report","volume":"11","author":"Ozaki Y","year":"2020","unstructured":"Ozaki Y, Yoshimura A, Sawaki M, et al.. Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: a case report. World J Clin Oncol. 2020, 11:504-9. 10.5306\/wjco.v11.i7.504","journal-title":"World J Clin Oncol"},{"key":"ref17","article-title":"[Clinical analysis of 12 cases of pneumothorax during intensive chemotherapy for malignant neoplasms]","volume":"37","author":"Yamada N","year":"2010","unstructured":"Yamada N, Abe N, Usui K, et al.. [Clinical analysis of 12 cases of pneumothorax during intensive chemotherapy for malignant neoplasms]. Gan To Kagaku Ryoho. 2010, 37:1519-23.","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2015.01.005","article-title":"Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory\/recurrent solid tumors","volume":"50","author":"Interiano RB","year":"2015","unstructured":"Interiano RB, McCarville MB, Wu J, Davidoff AM, Sandoval J, Navid F. Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory\/recurrent solid tumors. J Pediatr Surg. 2015, 50:1484-9. 10.1016\/j.jpedsurg.2015.01.005","journal-title":"J Pediatr Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003233421207","article-title":"Spontaneous pneumothorax","volume":"342","author":"Sahn SA","year":"2000","unstructured":"Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000, 342:868-74. 10.1056\/NEJM200003233421207","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2012.11680856","article-title":"Spontaneous pneumothorax in children with osteosarcoma: report of three cases and review of the literature","volume":"112","author":"Fayda M","year":"2012","unstructured":"Fayda M, Kebudi R, Dizdar Y, Gorgun O, Gun F, Aksu G, Ayan I. Spontaneous pneumothorax in children with osteosarcoma: report of three cases and review of the literature. Acta Chir Belg. 2012, 112:378-81. 10.1080\/00015458.2012.11680856","journal-title":"Acta Chir Belg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008323632078","article-title":"Spontaneous pneumothorax in malignancy: a case report and review of the literature","volume":"11","author":"Srinivas S","year":"2000","unstructured":"Srinivas S, Varadhachary G. Spontaneous pneumothorax in malignancy: a case report and review of the literature. Ann Oncol. 2000, 11:887-9. 10.1023\/a:1008323632078","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2003.18.2.277","article-title":"Bilateral spontaneous pneumothorax during cytotoxic chemotherapy for angiosarcoma of the scalp: a case report","volume":"18","author":"Lee CH","year":"2003","unstructured":"Lee CH, Park KU, Nah DY, Won KS. Bilateral spontaneous pneumothorax during cytotoxic chemotherapy for angiosarcoma of the scalp: a case report. J Korean Med Sci. 2003, 18:277-80. 10.3346\/jkms.2003.18.2.277","journal-title":"J Korean Med Sci"},{"key":"ref23","article-title":"Spontaneous pneumothorax during adjuvant chemotherapy for soft-tissue sarcoma","volume":"148","author":"Markman M","year":"1981","unstructured":"Markman M, Meek AG, Wingard JR. Spontaneous pneumothorax during adjuvant chemotherapy for soft-tissue sarcoma. Johns Hopkins Med J. 1981, 148:264-5.","journal-title":"Johns Hopkins Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s1010-7940(97)01164-0","article-title":"Spontaneous pneumothorax from radiographically occult metastatic sarcoma","volume":"11","author":"Furrer M","year":"1997","unstructured":"Furrer M, Althaus U, Ris HB. Spontaneous pneumothorax from radiographically occult metastatic sarcoma. Eur J Cardiothorac Surg. 1997, 11:1171-3. 10.1016\/s1010-7940(97)01164-0","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp233","article-title":"Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study","volume":"20","author":"Van Cutsem E","year":"2009","unstructured":"Van Cutsem E, Rivera F, Berry S, et al.. Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol. 2009, 20:1842-7. 10.1093\/annonc\/mdp233","journal-title":"Ann Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080455","article-title":"Understanding and managing the possible adverse effects associated with bevacizumab","volume":"66","author":"Shord SS","year":"2009","unstructured":"Shord SS, Bressler LR, Tierney LA, Cuellar S, George A. Understanding and managing the possible adverse effects associated with bevacizumab. Am J Health Syst Pharm. 2009, 66:999-1013. 10.2146\/ajhp080455","journal-title":"Am J Health Syst Pharm"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70112-3","article-title":"Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis","volume":"10","author":"Hapani S","year":"2009","unstructured":"Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol. 2009, 10:559-68. 10.1016\/S1470-2045(09)70112-3","journal-title":"Lancet Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0847","article-title":"Platelets take up the monoclonal antibody bevacizumab","volume":"13","author":"Verheul HM","year":"2007","unstructured":"Verheul HM, Lolkema MP, Qian DZ, et al.. Platelets take up the monoclonal antibody bevacizumab. Clin Cancer Res. 2007, 13:5341-7. 10.1158\/1078-0432.CCR-07-0847","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.81.333","article-title":"Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report","volume":"81","author":"Yanagihara K","year":"2014","unstructured":"Yanagihara K, Takei H, Iida S, et al.. Grade 4 epistaxis in a woman with metastatic breast cancer treated with bevacizumab: a case report. J Nippon Med Sch. 2014, 81:333-6. 10.1272\/jnms.81.333","journal-title":"J Nippon Med Sch"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyu023","article-title":"Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case","volume":"44","author":"Ikeda S","year":"2014","unstructured":"Ikeda S, Sekine A, Kato T, et al.. Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case. Jpn J Clin Oncol. 2014, 44:497-500. 10.1093\/jjco\/hyu023","journal-title":"Jpn J Clin Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.51","article-title":"Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis","volume":"305","author":"Ranpura V","year":"2011","unstructured":"Ranpura V, Hapani S, Wu S. Treatment-related mortality with bevacizumab in cancer patients: a meta-analysis. JAMA. 2011, 305:487-94. 10.1001\/jama.2011.51","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara N","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004, 25:581-611. 10.1210\/er.2003-0027","journal-title":"Endocr Rev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin DJ","year":"2005","unstructured":"Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005, 23:1011-27. 10.1200\/JCO.2005.06.081","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain RK","year":"2005","unstructured":"Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005, 307:58-62. 10.1126\/science.1104819","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10259","article-title":"Inhibition of VEGF receptors causes lung cell apoptosis and emphysema","volume":"106","author":"Kasahara Y","year":"2000","unstructured":"Kasahara Y, Tuder RM, Taraseviciene-Stewart L, et al.. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000, 106:1311-9. 10.1172\/JCI10259","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20255","article-title":"VEGF-induced intracellular Ca2+ oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells","volume":"8","author":"Lodola F","year":"2017","unstructured":"Lodola F, Laforenza U, Cattaneo F, et al.. VEGF-induced intracellular Ca2+ oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells. Oncotarget. 2017, 8:95223-46. 10.18632\/oncotarget.20255","journal-title":"Oncotarget"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106918-pneumothorax-as-a-complication-of-bevacizumab-containing-chemotherapy-a-systematic-review-of-case-reports","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:54Z","timestamp":1707507354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106918-pneumothorax-as-a-complication-of-bevacizumab-containing-chemotherapy-a-systematic-review-of-case-reports"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.27338","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,27]]}}}